subjects/setting: free-living, overweight and obese adults (n=204, body mass index 25 to 45) with baseline ldl cholesterol levels 130 to 200 mg/dl (3.4 to 5.2 mmol/l) were randomized; 144 were included in the main analysis of participants who completed the trial without significant protocol violations.